Correlation Between Arrowhead Pharmaceuticals and Biocardia

Can any of the company-specific risk be diversified away by investing in both Arrowhead Pharmaceuticals and Biocardia at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arrowhead Pharmaceuticals and Biocardia into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Arrowhead Pharmaceuticals and Biocardia, you can compare the effects of market volatilities on Arrowhead Pharmaceuticals and Biocardia and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arrowhead Pharmaceuticals with a short position of Biocardia. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arrowhead Pharmaceuticals and Biocardia.

Diversification Opportunities for Arrowhead Pharmaceuticals and Biocardia

-0.23

Correlation Coefficient

Arrowhead Pharmaceuticals  Biocardia

Very good diversification

The 3 months correlation between Arrowhead and Biocardia is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Arrowhead Pharmaceuticals and Biocardia in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biocardia and Arrowhead Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arrowhead Pharmaceuticals are associated (or correlated) with Biocardia. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biocardia has no effect on the direction of Arrowhead Pharmaceuticals i.e., Arrowhead Pharmaceuticals and Biocardia go up and down completely randomly.

Pair Corralation between Arrowhead Pharmaceuticals and Biocardia

Given the investment horizon of 90 days Arrowhead Pharmaceuticals is expected to generate 0.37 times more return on investment than Biocardia. However, Arrowhead Pharmaceuticals is 2.74 times less risky than Biocardia. It trades about -0.01 of its potential returns per unit of risk. Biocardia is currently generating about -0.02 per unit of risk. If you would invest  3,460  in Arrowhead Pharmaceuticals on October 5, 2024 and sell it today you would lose (1,495) from holding Arrowhead Pharmaceuticals or give up 43.21% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.79%
Values	Daily Returns

Arrowhead Pharmaceuticals  vs.  Biocardia

Arrowhead Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Arrowhead Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady basic indicators, Arrowhead Pharmaceuticals reported solid returns over the last few months and may actually be approaching a breakup point.

Biocardia

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Biocardia has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Pair Trading with Arrowhead Pharmaceuticals and Biocardia

The main advantage of trading using opposite Arrowhead Pharmaceuticals and Biocardia positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arrowhead Pharmaceuticals position performs unexpectedly, Biocardia can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biocardia will offset losses from the drop in Biocardia's long position.

The idea behind Arrowhead Pharmaceuticals and Biocardia pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.